N1-(2-Aminophenyl)-N8-phenyloctanediamide
| Title | Journal |
|---|---|
| Histone deacetylase inhibitor BML-210 induces growth inhibition and apoptosis and regulates HDAC and DAPC complex expression levels in cervical cancer cells. | Molecular biology reports 20121201 |
| DNA methyltransferase inhibitor RG108 and histone deacetylase inhibitors cooperate to enhance NB4 cell differentiation and E-cadherin re-expression by chromatin remodelling. | Cell biology international 20121101 |
| Response of retinoic acid-resistant KG1 cells to combination of retinoic acid with diverse histone deacetylase inhibitors. | Annals of the New York Academy of Sciences 20090801 |
| Retinoic acid and histone deacetylase inhibitor BML-210 inhibit proliferation of human cervical cancer HeLa cells. | Annals of the New York Academy of Sciences 20061201 |
| The novel histone deacetylase inhibitor BML-210 exerts growth inhibitory, proapoptotic and differentiation stimulating effects on the human leukemia cell lines. | European journal of pharmacology 20061107 |
| Histone deacetylase inhibitors reverse gene silencing in Friedreich's ataxia. | Nature chemical biology 20061001 |
| Novel inhibitors of human histone deacetylases: design, synthesis, enzyme inhibition, and cancer cell growth inhibition of SAHA-based non-hydroxamates. | Journal of medicinal chemistry 20050224 |
| Thiol-based SAHA analogues as potent histone deacetylase inhibitors. | Bioorganic & medicinal chemistry letters 20040621 |
| Novel histone deacetylase inhibitors: design, synthesis, enzyme inhibition, and binding mode study of SAHA-based non-hydroxamates. | Bioorganic & medicinal chemistry letters 20031215 |